DE69131014D1 - Rekombinante avirulente salmonella antifruchtbarkeitsimpfstoffe - Google Patents

Rekombinante avirulente salmonella antifruchtbarkeitsimpfstoffe

Info

Publication number
DE69131014D1
DE69131014D1 DE69131014T DE69131014T DE69131014D1 DE 69131014 D1 DE69131014 D1 DE 69131014D1 DE 69131014 T DE69131014 T DE 69131014T DE 69131014 T DE69131014 T DE 69131014T DE 69131014 D1 DE69131014 D1 DE 69131014D1
Authority
DE
Germany
Prior art keywords
avirulent salmonella
recombinant avirulent
fertility
vaccine
salmonella anti
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69131014T
Other languages
English (en)
Other versions
DE69131014T2 (de
Inventor
Roy Curtiss
Kenneth Tung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Washington University in St Louis WUSTL
Original Assignee
University of Washington
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Washington University in St Louis WUSTL filed Critical University of Washington
Publication of DE69131014D1 publication Critical patent/DE69131014D1/de
Application granted granted Critical
Publication of DE69131014T2 publication Critical patent/DE69131014T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
    • C12Y102/01—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
    • C12Y102/01011—Aspartate-semialdehyde dehydrogenase (1.2.1.11)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
DE69131014T 1990-11-21 1991-11-20 Rekombinante avirulente salmonella antifruchtbarkeitsimpfstoffe Expired - Fee Related DE69131014T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61572090A 1990-11-21 1990-11-21
US79134791A 1991-11-18 1991-11-18
PCT/US1991/008688 WO1992009684A1 (en) 1990-11-21 1991-11-20 Recombinant avirulent salmonella antifertility vaccines

Publications (2)

Publication Number Publication Date
DE69131014D1 true DE69131014D1 (de) 1999-04-22
DE69131014T2 DE69131014T2 (de) 1999-10-07

Family

ID=27087577

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69131014T Expired - Fee Related DE69131014T2 (de) 1990-11-21 1991-11-20 Rekombinante avirulente salmonella antifruchtbarkeitsimpfstoffe

Country Status (9)

Country Link
US (1) US5656488A (de)
EP (1) EP0558631B1 (de)
AT (1) ATE177787T1 (de)
AU (1) AU9094191A (de)
CA (1) CA2096529C (de)
DE (1) DE69131014T2 (de)
ES (1) ES2133311T3 (de)
IL (1) IL100121A (de)
WO (1) WO1992009684A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69133219T2 (de) * 1990-11-09 2004-02-12 Washington University Avirulente salmonella mikroben mit einer mutation in dem cdt gen und ihre verwendung
US5480799A (en) * 1993-12-10 1996-01-02 The University Of North Carolina At Chapel Hill Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope
ATE312934T1 (de) * 1995-06-07 2005-12-15 Univ Washington Rekombinant bakterielle system mit umweltbeschränkte lebensfähigkeit
US5922583A (en) * 1995-10-17 1999-07-13 Biostar Inc. Methods for production of recombinant plasmids
CA2286210A1 (en) * 1997-04-18 1998-10-29 Gesellschaft Fur Biotechnologische Forschung Mbh (Gbf) Attenuated salmonella strain used as a vehicle for oral immunization
DE19720761A1 (de) * 1997-05-07 1998-11-12 Schering Ag Verfahren zur Synthese und Sekretion von zur Kontrazeption geeigneter Proteine oder Proteinfragmente durch attenuierte Salmonellen oder einen anderen Gram-negativen attenuierten Impfstamm zur Erzeugung einer oralen Vakzinierung
US6024961A (en) * 1997-11-14 2000-02-15 Washington University Recombinant avirulent immunogenic S typhi having rpos positive phenotype
EP1140151A2 (de) * 1998-12-22 2001-10-10 Dalhousie University Zusammensetzungen und methode zur verminderung oder reduzierung der fertilität bei fisch und geflügel
AU5909500A (en) * 1999-07-01 2001-01-22 University Of Georgia Research Foundation, Inc., The Method and composition for affecting reproductive systems
WO2001074383A1 (en) * 2000-04-03 2001-10-11 Uab Research Foundation Chimeric antigen-enterotoxin mucosal immunogens
US6780405B1 (en) 2000-04-28 2004-08-24 Avant Immunotherapeutics, Inc. Regulated antigen delivery system (RADS)
US6872547B1 (en) 2000-10-11 2005-03-29 Washington University Functional balanced-lethal host-vector systems
WO2002040046A1 (en) * 2000-11-16 2002-05-23 Akzo Nobel N.V. Salmonella vaccine
US20040137003A1 (en) * 2001-04-30 2004-07-15 Curtiss Iii Roy Regulated antigen delivery system (rads)
US20050096283A1 (en) * 2001-12-14 2005-05-05 The Regents Of University Of California Methods of inhibiting fertility
US20050009188A1 (en) * 2002-09-19 2005-01-13 Kitto G. Barrie Animal immunocontraceptives expressed in plants and uses thereof
WO2004062597A2 (en) * 2003-01-09 2004-07-29 The Trustees Of The University Of Pennsylvania Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
WO2005093043A1 (en) * 2004-02-27 2005-10-06 Research Development Foundation Dna immunocontraceptive vaccines and uses thereof
US8802419B2 (en) 2006-03-02 2014-08-12 University Of Massachusetts Modified pathogens for use as vaccines
EP2150616A4 (de) 2007-05-10 2011-07-27 Univ Arizona Geregelte antigensynthese und/oder geregelte attenuation zur verbesserung der impfstoff immunogenität und/oder -sicherheit
EP2152883A4 (de) * 2007-05-10 2010-10-27 Univ Arizona Rekombinante bakterien mit vektoren zur expression von nukleinsäuresequenzencodierenden antigenen
US9040059B2 (en) 2007-10-05 2015-05-26 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium capable of eliciting a protective immune response against C. perfringens
WO2010045620A1 (en) 2008-10-17 2010-04-22 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae
US9163219B2 (en) 2009-04-14 2015-10-20 Arizona Board Of Regents On Behalf Of Arizona State University Single expression vector for generation of a virus with a segmented genome
WO2010135563A1 (en) 2009-05-22 2010-11-25 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium and methods of antigen and nucleic acid delivery
US9045742B2 (en) 2009-05-29 2015-06-02 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant Edwardsiella bacterium
US9062297B2 (en) 2010-01-13 2015-06-23 The Arizona Board Of Regents For And On Behalf Of Arizona State University Yersinia pestis vaccine
WO2011091291A1 (en) 2010-01-22 2011-07-28 The Arizona Board Of Regents For And On Behalf Of Arizona State University BACTERIUM COMPRISING A REGULATED rfaH NUCLEIC ACID
US9598697B2 (en) 2010-05-28 2017-03-21 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium to decrease tumor growth
US9255283B2 (en) 2010-07-02 2016-02-09 The Arizona Board Of Regents For And On Behalf Of Arizona State University Compositions and methods for bacterial lysis and neutral lipid production
US9303264B2 (en) 2012-05-18 2016-04-05 The Arizona Board Of Regents For And On Behalf Of Arizona State University Photosynthetic microorganisms expressing thermostable lipase
US9580718B2 (en) 2013-06-17 2017-02-28 Arizona Board Of Regents On Behalf Of Arizona State University Attenuated live bacteria with increased acid resistance and methods of use thereof
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
CN112618706B (zh) * 2020-11-21 2021-09-14 青岛博霖生物科技有限公司 沙门氏菌、鸭疫里默氏杆菌、大肠埃希氏杆菌病三联疫苗

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992520A (en) * 1974-11-27 1976-11-16 Merck & Co., Inc. Anti-fertility vaccine comprising solubilized zona pellucida and anti-serum
US4190495A (en) * 1976-09-27 1980-02-26 Research Corporation Modified microorganisms and method of preparing and using same
US4968619A (en) * 1976-09-27 1990-11-06 Research Corporation Modified microorganisms and method of preparing and using same
US4585651A (en) * 1978-10-17 1986-04-29 Stolle Research & Development Corporation Active/passive immunization of the internal female reproductive organs
US4392997A (en) * 1981-07-06 1983-07-12 Northwestern University Antigenic peptide compounds
US4888170A (en) * 1981-10-22 1989-12-19 Research Corporation Vaccines obtained from antigenic gene products of recombinant genes
US4585587A (en) * 1984-10-19 1986-04-29 Northwestern University Antigenic peptide compounds
US4795634A (en) * 1986-03-14 1989-01-03 Aphton Corporation Method for contraception by immunization against the zona pellucida
EP0270056A1 (de) * 1986-12-01 1988-06-08 Northwestern University Menschliche LDH-C4-cDNA-Sequenzen, die für antigene Bereiche kodieren
US4996297A (en) * 1987-10-07 1991-02-26 Zonagen, Inc. Recombinantly expressed rabbit zona pellucida polypeptides
US4990596A (en) * 1989-02-16 1991-02-05 Northwestern University Synthetic peptide producing antibodies of enhanced binding to human LDH-C4
AU636895B2 (en) * 1989-06-12 1993-05-13 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Contraceptive vaccine based on cloned zona pellucida gene
AU8328591A (en) * 1990-08-27 1992-03-17 Akzo N.V. Human zona pellucida protein zp3

Also Published As

Publication number Publication date
US5656488A (en) 1997-08-12
EP0558631A1 (de) 1993-09-08
EP0558631A4 (en) 1995-11-22
CA2096529A1 (en) 1992-05-22
DE69131014T2 (de) 1999-10-07
CA2096529C (en) 2003-01-21
ATE177787T1 (de) 1999-04-15
EP0558631B1 (de) 1999-03-17
WO1992009684A1 (en) 1992-06-11
AU9094191A (en) 1992-06-25
ES2133311T3 (es) 1999-09-16
IL100121A (en) 1998-06-15

Similar Documents

Publication Publication Date Title
DE69131014D1 (de) Rekombinante avirulente salmonella antifruchtbarkeitsimpfstoffe
DE69633617D1 (de) Il-17 receptor
TW283716B (de)
UA32525C2 (uk) Стійка до шлункового соку форма лікарського засобу на основі пантопразолу для орального введення
DE69327534T2 (de) Impfstoffe gegen diphtherietoxin
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
EP0835133A4 (de) Rekombinierte pockenvirus-tollwut zusammensetzung und kombinierte zusammensetzungen und deren verwendung
FI953442A0 (fi) Gonadotropiinia sisältäviä pakastekuivattuja pallosia
IT8820747V0 (it) Perfezionamento negli stivali del tipo cosiddetto da motocross.
NO20005672L (no) Svekkede Salmonella-mutanter som konstitutivt uttrykker Vi- antigenet
ATE177757T1 (de) Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
GB9808327D0 (en) Antidiotypic compounds
ES8500997A1 (es) Un metodo para producir un peptido.
DE69131200D1 (en) Herpes simplex virus vp16 impfstoffe
DE69230671T2 (de) Impfstoffe gegen actinobacillus pleuropneumonie
ATE93388T1 (de) Paracetamol enthaltende arzneizubereitung.
UA42741C2 (uk) Пептид маститної вакцини (варіанти), пептид складного антигенного представлення (варіанти), фармацевтична композиція (варіанти)
JPS5312958A (en) Mercapto group-containing silicone rubber composition
BR0011478A (pt) Composição de combinação imunológica, métodos de induzir uma resposta imunológica em um animal, e de imunizar um hospedeiro contra infecção pneumocócica, e, composição imunogênica para administração intranasal
ITRM920535A1 (it) Composizione farmaceutica per la somministrazione attraverso le mucose.
ZA97459B (en) Composition and methods for administering borrelia burgdorferi antigens.
FR2671974B1 (de)
GR3021983T3 (en) Cross-reactive influenza a immunization
MX9708226A (es) Vacunas que contienen una saponina y un esterol.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee